This suggests a dual function of CD44—as a promoter of pro-inflammatory signals and a potential stabilizer of the IL-37/IL-1R8 complex—which opens up new therapeutic possibilities in the context of diseases associated with immune system deregulation, such as sepsis, viral infections (e.g., COVID-19) or autoimmune diseases [22]. Here, CD44 is linked to autoimmune disease.